Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
131.54
+1.55 (+1.19%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,319,552
Open
132.61
Bid (Size)
131.40 (4)
Ask (Size)
132.38 (10)
Prev. Close
129.99
Today's Range
131.30 - 133.50
52wk Range
77.95 - 148.15
Shares Outstanding
N/A
Dividend Yield
1.34%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Here's My Top Growth Stock to Buy Right Now
July 20, 2024
Hims & Hers shares have multi-bagger growth potential over the years to come.
Via
The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
July 20, 2024
They're small now, but these stocks could grow much larger.
Via
The Motley Fool
Performance
YTD
+28.82%
+28.82%
1 Month
-7.34%
-7.34%
3 Month
+5.01%
+5.01%
6 Month
+24.69%
+24.69%
1 Year
+62.32%
+62.32%
More News
Read More
Craze For Ozempic And Zepbound For Weight Loss Leave Diabetic Patients Without Critical GLP-1 Medications
July 19, 2024
Via
Benzinga
Novo Nordisk Options Trading: A Deep Dive into Market Sentiment
July 19, 2024
Via
Benzinga
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
Via
Investor's Business Daily
$1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today
July 17, 2024
Via
Benzinga
Eli Lilly's Famed Weight Loss Drug Zepbound Scores Chinese Approval
July 19, 2024
Via
Benzinga
7 A-Rated Stock Picks With Huge Upside Potential
July 19, 2024
Via
InvestorPlace
Is Viking Therapeutics a Millionaire-Maker?
July 19, 2024
Via
The Motley Fool
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
July 18, 2024
Via
Benzinga
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
July 18, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy
July 18, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio
July 17, 2024
Via
InvestorPlace
Novo Nordisk Faces Setback in Netherlands Over Wegovy Insurance Coverage
July 17, 2024
Via
Benzinga
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
July 17, 2024
Via
The Motley Fool
Pfizer And Roche Advance On Their Weight Loss Drug Journeys
July 17, 2024
Via
Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
July 17, 2024
Via
Benzinga
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
July 17, 2024
Via
Investor's Business Daily
3 Hot Growth Stocks That Will Make You Forget About AMD
July 16, 2024
Via
InvestorPlace
Senate To Review Novo Nordisk's Levemir Insulin Discontinuation
July 16, 2024
Via
Benzinga
3 Dow Jones Stocks to Buy at 52-Week Lows in July
July 16, 2024
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
July 15, 2024
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges
July 15, 2024
Via
Benzinga
7 Top-Quality Stocks to Buy Now: July 2024
July 15, 2024
Via
InvestorPlace
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
July 15, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.